Neurotransmitter receptor binding and drug discovery.
D015762:2-Chloroadenosine; D000241:Adenosine / Q000031:analogs & derivatives / Q000378:metabolism; D000818:Animals; D001463:Barbiturates / Q000378:metabolism; D001667:Binding, Competitive; D003975:Diazepam / Q000378:metabolism; D010660:Phenylisopropyladenosine / Q000378:metabolism; D011955:Receptors, Drug / Q000378:metabolism*; D011963:Receptors, GABA-A; D017981:Receptors, Neurotransmitter / Q000378:metabolism*; D011983:Receptors, Purinergic; D014970:Xanthines / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D001463:Barbiturates; D011955:Receptors, Drug; D011963:Receptors, GABA-A; D017981:Receptors, Neurotransmitter; D011983:Receptors, Purinergic; D014970:Xanthines; D015762:2-Chloroadenosine; D010660:Phenylisopropyladenosine; C027512:1,3-diethyl-8-phenylxanthine; D005680:gamma-Aminobutyric Acid; D000241:Adenosine; D003975:Diazepam